Drugmaker Vertex to delay new clinical studies due to coronavirus
March 27, 2020 at 08:14 AM EDT
U.S. drugmaker Vertex Pharmaceuticals Inc said on Friday it would delay starting some clinical trials and temporarily pause enrolment in some studies, as it looks to free up hospitals to deal with the coronavirus outbreak.